Researchers have developed a new blood test that shows promise for detecting pancreatic cancer at earlier, more treatable stages. The test works by identifying specific protein biomarkers associated with the disease. In a recent study, it demonstrated high accuracy in distinguishing between patients with pancreatic cancer and healthy individuals. Early detection is critical for pancreatic cancer, which is often diagnosed too late for effective intervention. This non-invasive method could become a valuable screening tool for high-risk populations. Further validation in larger clinical trials is needed before it can be widely adopted. Read the full article at: https://www.sciencedaily.com/releases/2026/03/260323005540.htm